The enzyme enhancer of zeste homolog 2 (EZH2) is known for its role in transcriptional repression through histone modification, and its overexpression is the culprit for the progression and immune evasion of “cold” prostate cancer (PCa). This evidence concerns the gene EZH2 and posterior cortical atrophy.